Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지

Radiotherapy for Nasopharyngeal Carcinoma

비인강암의 방사선치료 성적

  • Lee, Myung-Za (Department of Radiation Therapy, College of Medicine, Hanyang University) ;
  • Chun, Ha-Chung (Department of Radiation Therapy, College of Medicine, Hanyang University)
  • 이명자 (한양대학교 의과대학 치료방사선학교실) ;
  • 전하정 (한양대학교 의과대학 치료방사선학교실)
  • Published : 2003.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To evaluate the results of radiation management on recurrence, survival and prognostic factors of patients with nasopharyngeal cancer Materials and Methods: Forty-nine patients, treated for nasopharyngeal cancer by radiotherapy between January 1984 and June 2000, were retrospectively studied. All patients were followed up for at least 2.5 years. Their median age was 52 years (range 17$\~$78). The histological types were 21 squamous cell carcinoma, 25 undifferentiated carcinoma, and 3 adenoid cystic carcinoma. The tumor stages were as follows: T1 in 14 patients, T2 in 24, T3 in 3, and T4 in 8, and N0 in 17 patients, Nl in 15, N2 in 4 and N3 in 13. Stages I, IIa, IIb ,III, IV and IVb were 4, 7, 12, 5, 8, and 13 patients respectively. Radiation doses of 58$\~$70 Gy (median 68.7 Gy) were given to the nasopahryngeal and involved lymphatic areas and of 46 $\~$ 50 Gy to the uninvolved neck areas. Results: The overall 5 and 10-year actuarial and disease free survival rates were 54.53$\%$ and 47$\%$ and 55.7$\%$ and 45.3$\%$, respectively The overall five-year survival rates were 100$\%$ in stage I , 80$\%$ in stage IIa, 59.5$\%$ in stage IIIb, 40$\%$ in stage III, and 42.2$\%$ in stage IV tumors. Twenty-three patients fatted either loco-regionally or distantly. Incidences of local failure, regional failure and distant metastasis for the first failure were 20.4$\%$, 8.2$\%$ and 20.4$\%$, respectively. Local recurrences were 4.3$\%$ in T1, 12.5$\%$ in T2, 0$\%$ in T3, and 62.5$\%$ in T4 lesions. Distant metastasis was seen in 41.2$\%$ of N2-3 lesions. Fifty percent of local recurrence appeared within 2 years of treatment at the primary lesion, whereas 70$\%$ of distant metastasis appeared within 2 years following treatment. Young age, female, early T stage, N0 stage; and poorly differentiated carcinoma were all related with good survival. However only stage showed statistically significance. Conclusionn: Based on the results of this study, radiation therapy to nasopharyngeal cancer showed high local recurrence in T4 and increased metastasis in N2-3 lesions. To improve local failure, further radiation doses, such as stereotactic radiation or IMRT radiation, are necessary especially in T4 lesions. The high incidence of distant metastasis in positive lymph node patients, indicates that combined radiation and effective chemotherapeutic agents with appropriated schedule are necessary.

목적: 비인강암 환자에서 방사선치료 후 재발 양상, 생존율 및 생존율에 미치는 예후인자를 분석평가하기 위해 후향적으로 분석을 하였다. 대상 및 방법: 1984년 1월부터 2000년 6월까지 한양대학병원 치료방사선과에서 방사선치료를 위해 의뢰된 비인강암 49명을 대상으로 후향적 분석을 하였다. 추적기간은 평균 76개월이었고 최소 2년 6개월이었다. 연령분포는 17세부터 78세였고 중앙연령은 52세였다 조직병리상 편평상피세포암이 21예, 미분화암이 25예, 샘모양 낭암종이 3예였다. 미국암합동위원회의 1997년 개정판으로 재분류한 병기로 T1 14예, T2 24예, T3 3예, T4 8예였다. N0 17예, Nl 15예, N2 4예, N3 13예였다 병기군별은 stage I, IIa, IIb, III, IVa IVb가 각각 4예, 7예, 12예, 5예, 8예, 13예였다. 방사선은 원발병소나 임파선전이부위에 58$\~$70 Gy를 조사 시행하였다. 결과: 5년 생존율 및 10년 생존율은 각각 54.5$\%$ 및 47$\%$였다. 5년 무병 생존율 및 10년 무병생존율은 가각 55.7$\%$ 및 45.3$\%$였다. 병기별로 100$\%$, IIa 80$\%$, IIb 59.5$\%$, III 40$\%$, IV 42.2$\%$의 5년 생존율을 보였다. 총 23예의 재발을 보였고 10예(20.4$\%$)에서 국소 재발, 4예(8.2$\%$)에서 임파선재발, 10예(20.4$\%$)에서 원격전이가 있었다. 병기에 따른 국소재발률은 T1 2예(4.3$\%$),T23 예(12.5$\%$), T4 5예(62.6$\%$)로 T병기가 높을수록 재발률이 높았다. 원격전이는 N2-3환자에서 많았다(41.2$\%$). 국소 재발시기는 50$\%$가 2년 이내였고 원격 전이시기는 70$\%$에서 2년 이내였다. 예후로는 여성, 젊은 연령, 조기 T병기 및 조기 전체적인 병기 및 미분화세포가 생존율이 높았으며 그중 조기 T병기 및 전체적인 병기가 통계적인 유의성이 있었다. 결론: 비인강암의 방사선치료결과는 국소 재발률은 T4 병기에 높고 원격전이는 2$\~$3병기에 현저히 높음을 알 수 있었다. 국소재발을 낮추기 위해 특히 T4에서 좀더 많은 양의 방사선이 요구되며 방사선량을 높이기 위해 삼차원적인 치료계획을 이용한 입체조형 방사선 치료나 세기조절 방사선 치료 등이 필요하리라 생각되며 임파선전이환자에서 보다 효과적인 항암제와 방사선의 병용요법의 개발이 필요하리라 생각된다.

Keywords

References

  1. Perez CA. Nasopharynx.In:PerezCA,BradyLW,eds.Principles and Practice of Radiation oncology 3rd ed.Philadelphia,PA; Lippincott-Raven 1997;897-939
  2. Hoppe RT, Goffiner DR, Bagshaw MA. Carcinoma of the nasopharyngx: Eighteen years experience with megavoltage radiation therapy. Cancer 1976;37:2605-2612 https://doi.org/10.1002/1097-0142(197606)37:6<2605::AID-CNCR2820370607>3.0.CO;2-W
  3. MoenchHC,Phillips TL. Carcinoma of the nasopharynx: review of 146 patients with emphasis on radiation dose and time factors. Am J Surg 1981;124:515-518 https://doi.org/10.1016/0002-9610(72)90077-3
  4. Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors ofnasopharynx.IntJ Radia OncolBiolPhys 1981;7:447-453 https://doi.org/10.1016/0360-3016(81)90129-2
  5. Bedwineck JM, Perez CA, Keys DJ. Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx. Cancer 1980;45:2725-2729 https://doi.org/10.1002/1097-0142(19800601)45:11<2725::AID-CNCR2820451105>3.0.CO;2-1
  6. Dickson RI, Flores AD. Nasopharyngeal carcinoma: An evaluation of 134patients treatedbetween 1971-1980.Laryngoscope 1985;95:276-283
  7. Qin DX, Hu YH, Yan JH, et al. Analysis of 1379 patient with nasopharygeal carcinoma treatedd with radaition. Cancer 1988; 61:1117-1124 https://doi.org/10.1002/1097-0142(19880315)61:6<1117::AID-CNCR2820610611>3.0.CO;2-J
  8. Sanguineti G, Geara FB, Garden AS, et al. carcinoma of nasopharynx treated by raiotherapy alone:determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997;37: 985-996 https://doi.org/10.1016/S0360-3016(97)00104-1
  9. LeeAWM,PoonYF,FooW,etal. Retrospective analysissof5037 patients with nasopharyngeal carcinoma treated during 1976-1985:overallsurvivaland pattern of failure.IntJRadiat Oncol Biol Phys1992;23:261-270
  10. Shim YS, Yang HS. The clinico-statistical & follow upstudy of the nasopharyngealmalignanttumors.KoreanJOtolaryngol - ogy 1981;24:187-199
  11. Ahn YO, Shin MH. Cancerfacts and estimates, Seoul, Korea, 1993-1997. Report of Seoul Cancer Registry2003;268
  12. Lindberg RD. Distribution of cervical lymphnode metastases from squamous cell carcinoma of the upperrespiratory and digestive tracts. Cancer1972;29:1446-1449 https://doi.org/10.1002/1097-0142(197206)29:6<1446::AID-CNCR2820290604>3.0.CO;2-C
  13. Frezza G, Barbieri E, Emiliani E, et al. Patterns of failure in nasopharyngeal cancer treated with megavoltage irradiation. Radiat Oncol 1986;5:287-294 https://doi.org/10.1016/S0167-8140(86)80177-3
  14. Tang SG, Lin FJ, Chen MS, et al. Prognostic factor of nasopharyngeal carcinoma: a multivariate analysis. Int J Radiat Oncol Biol Phys 1990;19:1143-1149 https://doi.org/10.1016/0360-3016(90)90219-A
  15. Perez CA, Devineni VR, Marcial-VegaV,etal. Carcinoma of the nasopharynx: factorsaffecting prognosis. Int J Radiat Oncol Biol Phys1992;23:271-280
  16. ShinBC,MaSY,MoonCW,YumHY,JeungTS,YooMJ. Results of Radiotherapy in nasopharyngeal. Cancer J Korean Soc The Radiol Oncol 1995;13:215-223
  17. Valetini V, Balducci M, Ciarniello V, et al. Tumors of the nasopharynx. Review of 132 cases. Rays 1987;2:77-78
  18. YanJH,QinDX,HuYH,etal. Managementoflocal residual primary lesion of nasopharyngeal carcinoma (NPC)arehigherdoses beneficial? Int J Radiat Oncol Biol Phys1989;16:1465- 1469
  19. WangCC. improved localcontrolofnasopharyngealcarcinoma after intracavitarybrachytherapy boost. AmJClinOnc1991; 14:5-8
  20. Teo P, Leung SF, Choi P, et al. Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma. Br J Radiol 1994;67:181-185 https://doi.org/10.1259/0007-1285-67-794-181
  21. WangCC. Accerated hyperfractionatedradiationtherapycarcinoma of the nasopharynx: Technique and results. Cancer 1989;63:2461-2467 https://doi.org/10.1002/1097-0142(19890615)63:12<2461::AID-CNCR2820631217>3.0.CO;2-#
  22. LeeAWM,ChanDKK,FowlerJF,etal. Effectoftime,doseand fractionation on local control of nasoparyngeal carcinoma. Radiother Oncol 1995;36:24-31 https://doi.org/10.1016/0167-8140(95)01579-6
  23. Teo PMI, Leung SF, ChanATC,etal. Final reportof a randomized trial on altered fractionationed radiotherapy in nasopharyngeal carcinoma prelimatuarly terminated by significant increase inneurologicalcomplication.IntJ RadiatOncolBiol Phys 2000;48:1311-1322 https://doi.org/10.1016/S0360-3016(00)00786-0
  24. Leibel SA, Kutcher GJ, Harrison LB, et al. Improved dose distributions for 3D conformalboost treatment incarcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1991;20:823-833 https://doi.org/10.1016/0360-3016(91)90030-8
  25. Keum KC, Kim GW, Lee SH, et al. 3-Dimentional conformal radiation therapy incarcinoma of the nasopharynx. J Korean Soc The Radiol Oncol 1998;16:399-407
  26. TateDJ,AdlerJr,ChangSD,etal. Sterotacticradiosurgical boost following radiotherpy in primary nasopharyngeal carcinoma:impacton local control.IntJRadiatOncolBiolPhys 1999;45:915-921
  27. Sultanem K, Shu HK, Xia P, et al. Three-dimentional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma. The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2000;48:711-722 https://doi.org/10.1016/S0360-3016(00)00702-1
  28. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy inthetreatmentofnasopharyngealcarcinoma:an updateoftheUCSFexperience.IntJRadiatOncolBiol Phys 2002;53:12-22, 25
  29. Al-Sarraf M, Leblanc M, Giri PGS, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer. Phase III randomized intergroup study 0099. J Cli Oncol 1998;16:1310-1317 https://doi.org/10.1200/JCO.1998.16.4.1310
  30. Lin JC, Jan JS, Hsu CY, Liang WM,Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngealcarcinoma: positiveeffectonoveralland progression-free survival. J C l i n Oncol 2003;21:631-637
  31. Cheng SH, Jian JJ, Tsai SY, et al. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy.IntJRadiatOncolBiolPhys 2000;48:1323- 1330
  32. International Nasopharyngeal Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy(cispltin, epirubicin, bleomycin) plus radiotherapy vsradiotherapy alonen in stage IV (＞N2, M0) undifferentiatednasopharyngeal carcinoma:Apositiveeffect on progression free survival. Int J Radiat Oncol Biol Phys 1996;35:463-469
  33. Chua DT, Sham JS, Au GK, Choy D. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results ofamatchedcohort analysis. Int J Radiat Oncol Biol Phys2002;53:334-343
  34. Chan AT, Teo PM, Ngan RK, et al. Concurrent chemotherapy- radiotherapy compared with radiotherapy alone in locoregionallyadvancednasopharyngeal carcinoma: progressionfree survival analysis of a phase IIIrandomized trial. J Clin Oncol 2002;20:2038-2044 https://doi.org/10.1200/JCO.2002.08.149
  35. Park JH, Lee SW, Chang HS, et al. Concurrent chemoradiotherapy versus Radiation alone in nasopharyngeal carcinoma. Korean J ofHead and Neck Oncology 2002;18:30-35
  36. HongS,WuHG,ChieEK,etal. Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma. Int J RadiatOncolBiol Phys1999;45:901-905
  37. ChiKH,ChangYC,GuoWY,etal. A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 2002;1;52:1238-1244
  38. Lin JC, Chen KY, Jan JS, Hsu CY. Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma. Int J RadiatOncolBiol Phys1996;36:1127-1136